Pharmacological characterization of designer cathinonesin vitro

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans

(2012) CM Hysek et al.   BRITISH JOURNAL OF PHARMACOLOGY

Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone

(2012) Raul López-Arnau et al.   BRITISH JOURNAL OF PHARMACOLOGY

Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats

(2012) Pai-Kai Huang et al.   DRUG AND ALCOHOL DEPENDENCE

Noradrenergic α1 Receptor Antagonist Treatment Attenuates Positive Subjective Effects of Cocaine in Humans: A Randomized Trial

(2012) Thomas F. Newton et al.   PLoS One

Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

(2012) Cédric M. Hysek et al.   PLoS One

Mephedrone (4-methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats

(2011) Craig P. Motbey et al.   ADDICTION BIOLOGY

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats

(2011) J Kehr et al.   BRITISH JOURNAL OF PHARMACOLOGY

Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)

(2011) Adrian Derungs et al.   CLINICAL TOXICOLOGY

Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States

(2011) Henry A. Spiller et al.   CLINICAL TOXICOLOGY

A web-based survey on mephedrone

(2011) R.L. Carhart-Harris et al.   DRUG AND ALCOHOL DEPENDENCE

Cathinone derivatives: A review of their chemistry, pharmacology and toxicology

(2011) John P. Kelly   Drug Testing and Analysis

Interaction of mephedrone with dopamine and serotonin targets in rats

(2011) José Martínez-Clemente et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)

(2011) B. Di Cara et al.   JOURNAL OF NEUROSCIENCE

In Vivo Effects of Amphetamine Analogs Reveal Evidence for Serotonergic Inhibition of Mesolimbic Dopamine Transmission in the Rat

(2011) M. H. Baumann et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Abuse Liability Profile of Three Substituted Tryptamines

(2011) M. B. Gatch et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

(2011) Michael H Baumann et al.   NEUROPSYCHOPHARMACOLOGY

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

(2011) F. G. Revel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online

(2011) M. Coppola et al.   TOXICOLOGY LETTERS

Mephedrone, new kid for the chop?

(2010) Adam R. Winstock et al.   ADDICTION

Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function

(2010) Yasuteru Sano et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Instability of the ecstasy market and a new kid on the block: mephedrone

(2010) Tibor M Brunt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain

(2009) Z. Xie et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines

(2007) T Montgomery et al.   BRITISH JOURNAL OF PHARMACOLOGY